Physician

Majid Mani, M.D.

According to 2025 Medicare claims, Majid Mani, M.D. (NPI: 1043261373) practices ophthalmology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is CALIFORNIA RETINA ASSOCIATES, LP (NPI: 1114033404; TIN: 330298426) and primary practice location at 92243-9676.

Mani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,414 traditional Medicare patients, billed 8,262 HCPCS/CPT codes, and received $680,883 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 5,905 prescription claims across 1,192 beneficiaries totaling $757,197 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 28 records totaling $1,669. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $1,238,185 to $680,883. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $753,637 and ending at $757,197. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,047	13,085	$1,238,185
2016	1,978	19,726	$1,213,958
2017	1,881	13,993	$1,169,785
2018	1,474	9,891	$827,078
2019	1,105	7,252	$641,909
2020	1,093	6,992	$670,180
2021	1,223	7,661	$676,992
2022	1,299	8,339	$665,090
2023	1,233	8,000	$668,359
2024	1,414	8,262	$680,883

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,555	6,867	$753,637
2016	1,281	5,775	$547,253
2017	967	4,782	$383,401
2018	868	4,483	$416,523
2019	840	4,254	$385,160
2020	1,051	5,159	$470,933
2021	937	4,537	$468,825
2022	962	4,654	$710,437
2023	1,007	5,126	$941,998
2024	1,192	5,905	$757,197

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	292	292	$131
92014	Established patient complete exam of visual system	1,148	1,862	$91
92012	Established patient problem focused exam of visual system	359	424	$67
92134	Imaging of retina	975	1,753	$31
92250	Photography of the retina	566	588	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xiidra	Lifitegrast	125	6,300	$135,052
Cyclosporine	Cyclosporine	195	10,920	$106,856
Rocklatan	Netarsudil Mesylat/Latanoprost	245	7,431	$91,517
Restasis	Cyclosporine	72	3,540	$73,479
Lumigan	Bimatoprost	178	7,068	$70,995

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$1,669	ANI Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Majid Mani, M.D.?

Tedicare shows public-source Medicare data for Majid Mani, M.D. (NPI 1043261373), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Majid Mani, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Majid Mani, M.D.?

Majid Mani, M.D. is linked to CALIFORNIA RETINA ASSOCIATES, LP (billing NPI 1114033404) in the available physician profile data.

Does Majid Mani, M.D. have Open Payments data?

Majid Mani, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.